Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
AssigneeBiogen MA Inc.
InventorAaron DEYKIN
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiogen MA Inc.
InventorAaron DEYKIN
Estimating the term…
The present invention provides a method for treating multiple sclerosis (MS), and for reducing flu-like symptoms associated with administration of an interferon to a patient with MS. The method involves intramuscularly administering the interferon to the MS patient according to an escalating dosing regimen in weeks 1 to 3, and a full therapeutically effective dose of interferon in week 4. In one embodiment of the invention, the escalating dosing regimen comprises administering one quarter of the therapeutically effective dose in week 1, half of the therapeutically effective dose in week 2, and three-quarters of the therapeutically effective dose in week 3. Also provided are titration packages for enabling compliance with a regimen of changing dosage of an interferon over a period of time.
A method of titrating a dose of interferon-β-1a in a dosage titration regimen in a patient suffering from multiple sclerosis, the method comprising providing a titration package for titrating the dosage of interferon-β-1a weekly up to a full dosage of 30 μg of interferon-β-1a to the patient in week four so as to reduce the severity of flu-like symptoms associated with treating a patient having multiple sclerosis with intramuscularly administered interferon-β-1a, the method comprising:
Dependencies are inferred from the claim text.